Diabeloop is a startup based in France, most recent round Series-c-plus.
Based in France, Diabeloop is a startup. Its most recent tracked round is Series-c-plus.
Diabeloop develops CE‑marked medical devices and AI algorithms that connect continuous glucose monitors and insulin delivery systems to automate insulin dosing for people with diabetes, primarily type 1. Its products include the DBLG1 automated insulin delivery system and the YourLoops data app.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.